Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fujue Wang

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Translational Research|May 16, 2023
CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathwayZhengchang He, Shaoxian Shen, Yuyao Yi, et al.
International Journal of Biological Macromolecules|May 22, 2026
Single-cell and spatial transcriptomics reveal SPRR2A<sup>+</sup> epithelial-MMP1<sup>+</sup> fibroblast interactions as key drivers of Esophageal Squamous Cell Carcinoma progressionWenjie Yang, Yue Chen, Fujue Wang, et al.
Leukemia & Lymphoma|December 6, 2021
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both <i>in vitro</i> and <i>in vivo</i>Jun Li, Dan Liao, Fujue Wang, et al.
Anti-Cancer Drugs|June 19, 2021
Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case reportPengqiang Wu, Tao Ma, Yan Chen, et al.
Medicine|March 4, 2022
Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine: A case reportZhencang Zhou, Pengqiang Wu, Fujue Wang, et al.
Frontiers in Immunology|April 27, 2026
Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinomaJunyan He, Keling Pang, Zhigang Zhou, et al.
Frontiers in Cell and Developmental Biology|April 24, 2026
A novel immune-related gene signature stratifies prognosis and characterizes the tumor immune microenvironment in head and neck squamous cell carcinomaPian Li, Keling Pang, Zhigang Zhou, et al.
Frontiers in Oncology|April 4, 2025
Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphomaFujue Wang, Yu Gao, Yue Chen, et al.
Oncology Reports|June 16, 2023
Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathwayYingying Chen, Huan Tao, Fujue Wang, et al.
Frontiers in Oncology|October 24, 2022
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemiaPian Li, Junjun Li, Feng Wen, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Translational Research|May 16, 2023
CD31 promotes diffuse large B-cell lymphoma metastasis by upregulating OPN through the AKT pathway and inhibiting CD8+ T cells through the mTOR pathwayZhengchang He, Shaoxian Shen, Yuyao Yi, et al.
International Journal of Biological Macromolecules|May 22, 2026
Single-cell and spatial transcriptomics reveal SPRR2A<sup>+</sup> epithelial-MMP1<sup>+</sup> fibroblast interactions as key drivers of Esophageal Squamous Cell Carcinoma progressionWenjie Yang, Yue Chen, Fujue Wang, et al.
Leukemia & Lymphoma|December 6, 2021
RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both <i>in vitro</i> and <i>in vivo</i>Jun Li, Dan Liao, Fujue Wang, et al.
Anti-Cancer Drugs|June 19, 2021
Treatment of refractory diffuse large B-cell lymphoma by chidamide combined with autologous stem cell transplantation: a case reportPengqiang Wu, Tao Ma, Yan Chen, et al.
Medicine|March 4, 2022
Treatment of refractory MALT lymphoma by lenalidomide plus bendamustine: A case reportZhencang Zhou, Pengqiang Wu, Fujue Wang, et al.
Frontiers in Immunology|April 27, 2026
Regulatory B cell-related gene signature predicts prognosis and immune landscape in head and neck squamous cell carcinomaJunyan He, Keling Pang, Zhigang Zhou, et al.
Frontiers in Cell and Developmental Biology|April 24, 2026
A novel immune-related gene signature stratifies prognosis and characterizes the tumor immune microenvironment in head and neck squamous cell carcinomaPian Li, Keling Pang, Zhigang Zhou, et al.
Frontiers in Oncology|April 4, 2025
Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphomaFujue Wang, Yu Gao, Yue Chen, et al.
Oncology Reports|June 16, 2023
Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathwayYingying Chen, Huan Tao, Fujue Wang, et al.
Frontiers in Oncology|October 24, 2022
A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemiaPian Li, Junjun Li, Feng Wen, et al.
Pageof 3